Kovack Advisors’s DermTech, Inc. Common Stock DMTK Stock Holding History

Kovack Advisors’s Portfolio DMTK Stock Details DMTK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-11,600	Closed	-$42.7K	–	657
2023 Q1	$42.7K	Buy	+11,600	New	+$48.8K	0.01%	578
2022 Q2	–	Sell	-12,400	Closed	-$182K	–	761
2022 Q1	$182K	Buy	+12,400	New	+$166K	0.02%	657
2021 Q4	–	Sell	-7,300	Closed	-$234K	–	774
2021 Q3	$234K	Buy	7,300 +1,500	+26%	+$52.7K	0.03%	611
2021 Q2	$241K	Buy	+5,800	New	+$238K	0.03%	580
2019 Q4	–	Sell	-13,000	Closed	-$73K	–	563
2019 Q3	$73K	Buy	+13,000	New	+$155K	0.02%	459

Other funds holding DMTK

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Triatomic Management Palo Alto, California $3.39M AUM 3.35% 1-Year Est. Return

EPIQ Partners Minneapolis, Minnesota $236M AUM 15.39% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

WPC

White Pine Capital Bloomington, Minnesota $355M AUM 45.63% 1-Year Est. Return

Luther King Capital Management (LKCM) Fort Worth, Texas $23.1B AUM 21.31% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Kovack Advisors's DMTK Position: Q2 2023 in Review

Kovack Advisors sold out of DermTech, Inc. Common Stock (DMTK) in Q2 2023, closing a stake of 11,600 shares — an estimated $42.7K sold.

Kovack Advisors first reported a position in DMTK in Q3 2019 and held it in 5 quarters. The position peaked at $241K in Q2 2021. 85 funds tracked by Wall St. Rank hold DMTK as of Q2 2023.

Kovack Advisors reported no remaining DermTech, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
Kovack Advisors sold 11,600 DermTech, Inc. Common Stock shares in Q2 2023, an estimated $42.7K.
Kovack Advisors first reported a position in DermTech, Inc. Common Stock in Q3 2019 and held it in 5 quarters.
Kovack Advisors's DermTech, Inc. Common Stock position peaked at $241K in Q2 2021.
85 funds tracked by Wall St. Rank held DermTech, Inc. Common Stock as of Q2 2023.

Based on Kovack Advisors's 13F filing for Q2 2023, filed 21 Jul 2023.